Past events

2–6.30pm 16 April 2018
A symposium to celebrate the retirement of Emeritus Professor Angela Dulhunty   2 pm: Associate Professor Nicole Beard, Faculty of Education, Science, Technology and Mathematics, University of Canberra...
12–1pm 13 April 2018
Associate Professor Stuart Mannering, Head, Human T-cell Laboratory, Immunology and Diabetes Unit, St. Vincent's Institute of Medical Research, Melbourne, VIC Associate Professor Stuart Mannering completed his PhD, in...
5.30–7pm 10 April 2018
The Science of Us series investigates the science of our lives and our health, from the moment of conception through to death, focusing on some of the issues we face during our lives and what science is doing to resolve them...
11am–12pm 9 April 2018
Join Illumina's HT Sequencing Sr Product Marketing Manager, David Miller, for a talk on Illumina's NovaSeq Next Generation Sequencing Platform
12–1pm 6 April 2018
Associate Professor Peter Todd, Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA Nucleotide repeat expansions are a common cause of inherited neurodegenerative disease, including ALS, Huntington’...
5.30–6.15pm 26 March 2018
The immune system in infection and cancer Dr Si Ming Man, The Man Group - Innate Immunity and Inflammasomes, JCSMR Infectious diseases, such as food poisoning, sepsis, and pneumonia, are responsible for one-third of...
3.30–4.30pm 23 March 2018
Riemke Aggio-Bruce - The Natoli Group Eccles Institute of Neuroscience, JCSMR, ANU
12–1pm 16 March 2018
Professor Hai-Hui Xue, Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, USA CD8+ T cells are dedicated cytotoxic lymphocytes, and their identity must be tightly regulated during...
12–1pm 9 March 2018
Professor Warren Alexander, Joint Head, Cancer and Haematology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC The production of blood cells is exquisitely controlled to continuously and...
5.30–6.15pm 28 February 2018
Harnessing the power of patient samples to diagnose, understand and treat rare immune diseases Dr Julia Ellyard and Professor David Fulcher, Department of Immunology and Infectious Disease, The John Curtin School of Medical...
10am–11.30pm 23 February 2018
“Dysregulation of mRNA translation and energy metabolism in neoplasia.” by Associate Professor Ivan Topisirovic, Gerald Bronfman Dept of Oncology, Lady Davis Institute, Jewish General Hospital (Montreal, Canada)...
10.30–11.30am 20 February 2018
Associate Professor Matthew T. Weirauch, Centre for Autoimmune Genomics and Etiology, Divisions of Biomedical Informatics and Development Biology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA Gene regulation is...
10.30–11.30am 19 February 2018
Professor Clare Bryant, PhD, Department of Veterinary Medicine, University of Cambridge, U.K. Clare Bryant is Professor of Innate Immunity at the University of Cambridge. She graduated in Physiology and Biochemistry, then...
12–1pm 9 February 2018
Professor Steve P Watson, Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham The focus of the presentation will be on two platelet receptors, GPVI and CLEC-2,...
12–1pm 15 December 2017
Dr James Wang, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA Activated B cell like diffuse large B cell lymphoma (ABC-DLBCL) is an aggressive and incurable form of B cell malignancy. A hallmark...
12–1pm 8 December 2017
Dr Daniel Hu Highly self-reactive T cells within the thymus undergo apoptosis when they encounter their cognate antigens, and so are “negatively selected” from the conventional T cell fate. This process occurs at...
3.30–4.30pm 7 December 2017
Dr Owen Marshall, Menzies Institue, University of Tasmania, Hobart, TAS Dr Owen Marshall obtained his PhD in Professor Andy Choo’s group at the Murdoch Children’s Research Institute in 2008, working on the...
3.30–4.30pm 1 December 2017
Dr Juliette Cheyne, Auditory Neurobiology Research Group/Synaptic Function Research Group, University of Auckland, New Zealand
5.30–6.15pm 27 November 2017
Evidence based medical and science policy is increasingly under pressure to bow to commercial pressures and political ideology. But surely not in Australia...?   Should academics respond by staying removed, &...
12–1pm 24 November 2017
Professor Lars Nitschke, PhD,  Division of Genetics, Department of Biology, University of Erlangen, Germany The Nitschke group works on Siglec proteins, which are inhibiting receptors on immune cells that can bind sialic...

Pages

Updated:  22 June 2018/Responsible Officer:  Director, JCSMR/Page Contact:  Web Manager